FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
Source URL: https://qa1.novartis.us/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0